ANKRD2 and neoplasm: Due to the absence of a clear reversion of the phenotype in cells expressing Ankrd2(S99A) mutant, we assume that S99 is not essential for Ankrd2 functions related to tumor progression, and thus, cannot be considered a good therapeutic target to counteract cancer growth.